Showing results (261-270 of 307) with videos related to
Sort By:
Pageof 31
Chemmedchem|November 12, 2010
Structure-activity relationship study of 16 a-thiocamptothecins: an integrated in vitro and in silico approachCristian Samorì, Giovanni L Beretta, Greta Varchi, et al.Journal of Chemical Information and Modeling|May 28, 2013
Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonistsMagdalena Bacilieri, Antonella Ciancetta, Silvia Paoletta, et al.Bioorganic Chemistry|July 26, 2024
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positionsIlenia Grieco, Davide Bassani, Letizia Trevisan, et al.EMBO Reports|June 14, 2022
CG7630 is the Drosophila melanogaster homolog of the cytochrome c oxidase subunit COX7BMichele Brischigliaro, Alfredo Cabrera-Orefice, Mattia Sturlese, et al.Journal of Medicinal Chemistry|September 29, 2006
Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studiesVittoria Colotta, Daniela Catarzi, Flavia Varano, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2017
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profilesLucia Squarcialupi, Marco Betti, Daniela Catarzi, et al.Medchemcomm|August 16, 2018
Discovery of 2-aminoimidazole and 2-amino imidazolyl-thiazoles as non-xanthine human adenosine A3 receptor antagonists: SAR and molecular modeling studiesAmit N Pandya, Arshi B Baraiya, Hitesh B Jalani, et al.Journal of Medicinal Chemistry|August 9, 2002
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonistAnna Maconi, Giorgia Pastorin, Tatiana Da Ros, et al.Bioorganic & Medicinal Chemistry|May 13, 2008
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonistsVittoria Colotta, Daniela Catarzi, Flavia Varano, et al.Journal of Medicinal Chemistry|February 7, 2008
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationshipsAdriana Chilin, Roberto Battistutta, Andrea Bortolato, et al.Pageof 31